AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental drug did not significantly improve overall survival results for patients.

Share were down 4.9% by 9:43 a.m. London time.

This is a breaking news story. Please check back for updates.

Source

World

Philips shares pop 9% amid ‘clear step up in sales’; European stocks mixed

February 10, 2026

City of London skyline with 20 Fenchurch Street, affectionately nicknamed the Walkie Talkie as light fades at dusk on 27th November 2025 in London, United Kingdom. Mike Kemp | In Pictures | Getty Images European stocks opened in mixed territory on Tuesday amid a flurry of corporate earnings releases. By 8:30 a.m. in London (3:30 […]

World

Gucci-owner Kering jumps 13% as new CEO maps revival, sales beats estimates

February 10, 2026

Customers shop at a GUCCI luxury store in Shanghai, China. Cfoto | Future Publishing | Getty Images Kering said it expects a return to growth this year even as it posted another quarter of sales declines on Tuesday, with its biggest sales driver, Gucci, continuing to lag in new CEO Luca de Meo’s first quarter […]

World

Oil major BP suspends buybacks in fresh sign of oil price pressure

February 10, 2026

Trowbridge in Somerset, England, on March 15, 2025. Anna Barclay | Getty Images News | Getty Images British oil giant BP on Tuesday posted fourth-quarter profit in line with expectations and suspended share buybacks, seeking to shore up its balance sheet as lower crude prices take their toll. The London-listed energy firm reported underlying replacement […]